Pharmacogenetic Interactions of Rifapentine plus Isoniazid with Efavirenz or Nevirapine

OBJECTIVE: The effect of rifapentine plus isoniazid on efavirenz pharmacokinetics was characterized in AIDS Clinical Trials Group protocol A5279 (NCT01404312). The present analyses characterize pharmacogenetic interactions between these drugs, and with nevirapine. METHODS: A subset of HIV-positive i...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pharmacogenet Genomics
Hlavní autoři: Haas, David W., Podany, Anthony T., Bao, Yajing, Swindells, Susan, Chaisson, Richard E., Mwelase, Noluthando, Supparatpinyo, Khuanchai, Mohapi, Lerato, Gupta, Amita, Benson, Constance A., Baker, Paxton, Fletcher, Courtney V.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7655626/
https://ncbi.nlm.nih.gov/pubmed/32815870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0000000000000417
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky